Evidence map›Paper›PMID 36791060›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2023

FGF18 promotes human lung branching morphogenesis through regulating mesenchymal progenitor cells.

Soula Danopoulos, Randa Belgacemi, Renee F C Hein, Alyssa J Miller, Gail H Deutsch, Ian Glass, Jason R Spence, Denise Al Alam

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Elevated Senescence Markers in Developing Trisomy 21 Human Lungs.American journal of respiratory cell and molecular biology · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Soula DanopoulosLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California, United States.ORCID 0000-0002-2495-4445
Randa BelgacemiLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California, United States.ORCID 0000-0001-7884-3567
Renee F C HeinDepartment of Cell and Developmental biology, University of Michigan Medical School, Ann Arbor, Michigan, United States.ORCID 0000-0002-1614-2420
Alyssa J MillerDepartment of Cell and Developmental biology, University of Michigan Medical School, Ann Arbor, Michigan, United States.
Gail H DeutschDepartment of Laboratory Medicine and Pathology, University of Washington School of Medicine and Seattle Children's Research Institute, Seattle, Washington, United States.ORCID 0000-0002-0571-0285
Ian GlassDepartment of Pediatrics, University of Washington School of Medicine, Seattle, Washington, United States.
Jason R SpenceDepartment of Cell and Developmental biology, University of Michigan Medical School, Ann Arbor, Michigan, United States.
Denise Al AlamLundquist Institute for Biomedical Innovation, Harbor-UCLA Medical Center, Torrance, California, United States.ORCID 0000-0003-3148-7352
University of Michigan · USUniversity of California, Los Angeles · USSeattle Children's Hospital · USUCLA Medical Center · USUniversity of Washington · US

Funding

LABORATORY OF DEVELOPMENTAL BIOLOGYR24HD000836 · NICHD · UNIVERSITY OF WASHINGTON · PI Ian Amos Glass · 1995 to 2026
$16.9M
Type I IFN signaling during lung development in Down Syndrome-Multiome sequencing of human fetal and pediatric trisomy 21 lungsR01HL155104 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI DANOPOULOS, SOULA ATHANASIA · 2021 to 2025
$3.3M
Mechanisms controlling early human lung developmentR01HL141856 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI AL-ALAM, DENISE · 2018 to 2022
$2.5M
Type I interferon regulates angiogenesis in Down Syndrome SupplementR21HL165411 · NHLBI · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI AL-ALAM, DENISE, DANOPOULOS, SOULA ATHANASIA · 2022 to 2023
$507k
NHLBI NIH HHS R01 HL141856NHLBI NIH HHS R01 HL155104NHLBI NIH HHS R21 HL165411NICHD NIH HHS R24 HD000836
6 · The paper itself

Abstract

Fibroblast growth factor (FGF) signaling is known to play an important role in lung organogenesis. However, we recently demonstrated that FGF10 fails to induce branching in human fetal lungs as is observed in mouse. Our previous human fetal lung RNA sequencing data exhibited increased FGF18 during the pseudoglandular stage of development, suggestive of its importance in human lung branching morphogenesis. Whereas it has been previously reported that FGF18 is critical during alveologenesis, few studies have described its implication in lung branching, specifically in human. Therefore, we aimed to determine the role of FGF18 in human lung branching morphogenesis. Human fetal lung explants within the pseudoglandular stage of development were treated with recombinant human FGF18 in air-liquid interface culture. Explants were analyzed grossly to assess differences in branching pattern, as well as at the cellular and molecular levels. FGF18 treatment promoted branching in explant cultures and demonstrated increased epithelial proliferation as well as maintenance of the double positive SOX2/SOX9 distal bud progenitor cells, confirming its role in human lung branching morphogenesis. In addition, FGF18 treated explants displayed increased expression of SOX9, FN1, and COL2A1 within the mesenchyme, all factors that are important to chondrocyte differentiation. In humans, cartilaginous airways extend deep into the lung up to the 12th generation of branching whereas in mouse these are restricted to the trachea and main bronchi. Therefore, our data suggest that FGF18 promotes human lung branching morphogenesis through regulating mesenchymal progenitor cells.

Indexed as

Fibroblast Growth FactorsMesenchymal Stem CellsAnimalsHumansLungMiceMorphogenesisOrganogenesisfibroblast growth factor 18Fibroblast Growth Factorsbranching morphogenesisFGF18lung developmentmesenchymeprogenitor cells

Identifiers

PMID36791060
PMCPMC10027085
OpenAlexW4320856027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.